Zymeworks
ZYME
137 hedge funds and large institutions have $548M invested in Zymeworks in 2023 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 31 closing their positions.
102% more capital inflows, than outflows
Capital inflows: $119M | Capital outflows: $58.6M
71% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 31
19% more funds holding
Funds holding: 115 → 137 (+22)
13% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 31
10.3% more ownership
Funds ownership: 88.53% → 98.83% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
48% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $2.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EcoR1 Capital
San Francisco,
California
|
+$30M |
| 2 |
BlackRock
New York
|
+$25M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.74M |
| 4 |
Bridgeway Capital Management
Houston,
Texas
|
+$5.06M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Perceptive Advisors
New York
|
-$8.62M |
| 2 |
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.51M |
| 3 |
Millennium Management
New York
|
-$5.31M |
| 4 |
Rubric Capital Management (New York)
New York
|
-$4.45M |
| 5 |
Redmile Group
San Francisco,
California
|
-$3.64M |
ZYME Hedge Fund Activity: Q2 2023 in Review
137 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2023, worth a combined $548M — up 6.9% from $513M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new ZYME positions and 31 closed out — a net gain of 22 holders — while 35 added to existing stakes and 31 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $30M. The largest seller was Perceptive Advisors, cutting an estimated $8.62M.
- 137 institutional investors held Zymeworks (ZYME) as of Q2 2023, up from 115 in Q1 2023.
- Funds reported $548M of Zymeworks stock for Q2 2023, up 6.9% quarter-over-quarter.
- 53 funds opened new Zymeworks positions in Q2 2023 and 31 closed out, a net change of +22 holders.
- The largest Zymeworks buyer in Q2 2023 was EcoR1 Capital, an estimated $30M added.
- The largest Zymeworks seller in Q2 2023 was Perceptive Advisors, an estimated $8.62M sold.
Based on aggregated 13F filings for Q2 2023.